View:
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No.6 and Amendment No.8)*
QUESTCOR PHARMACEUTICALS INC.
- -------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- -------------------------------------------------------------------------------
(Title of Class of Securities)
232808105
- -------------------------------------------------------------------------------
(CUSIP Number)
Joseph J. Giunta, Esq.
Skadden, Arps, Slate, Meagher & Flom LLP
300 South Grand Avenue
Los Angeles, CA 90071
(213) 687-5000
- -------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications)
January 12, 2004
- -------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is filing
this schedule because of ss.240.13d-1(e), 240.13d-1(f) or 240.13d-(1)(g),
check the following box |_|.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
SCHEDULE 13D
- -------------------------------------------------------------------------------
CUSIP No. 232808105
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Claudio Cavazza
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |X|
(b) |_|
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 SOURCE OF FUNDS
- -------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
- -------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Italy
- -------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 0
SHARES ------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 14,631,375
EACH ------------------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON WITH 1,756,781
------------------------------------------------------
10 SHARED DISPOSITIVE POWER
10,668,712
- -------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
14,631,375
- -------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES |_|
- -------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
31.53%
- -------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
- -------------------------------------------------------------------------------
SCHEDULE 13D
- -------------------------------------------------------------------------------
CUSIP No. 232808105
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Paolo Cavazza
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |X|
(b) |_|
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 SOURCE OF FUNDS
- -------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
- -------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Italy
- -------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 0
SHARES ------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 14,631,375
EACH ------------------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON WITH 1,756,782
------------------------------------------------------
10 SHARED DISPOSITIVE POWER
11,117,812
- -------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
14,631,375
- -------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES |_|
- -------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
31.53%
- -------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
- -------------------------------------------------------------------------------
SCHEDULE 13D
- -------------------------------------------------------------------------------
CUSIP No. 232808105
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Sigma-Tau Finanziaria SpA
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) |X|
(b) |_|
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 SOURCE OF FUNDS
- -------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
- -------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Italy
- -------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 0
SHARES ------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 14,631,375
EACH ------------------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON WITH 0
------------------------------------------------------
10 SHARED DISPOSITIVE POWER
10,668,712
- -------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
14,631,375
- -------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES |_|
- -------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
31.53%
- -------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
CO
- -------------------------------------------------------------------------------
SCHEDULE 13D
- -------------------------------------------------------------------------------
CUSIP No. 232808105
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Sigma-Tau International S.A.
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) |X|
(b) |_|
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 SOURCE OF FUNDS
- -------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
- -------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Luxembourg
- -------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 0
SHARES ------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 14,631,375
EACH ------------------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON WITH 0
------------------------------------------------------
10 SHARED DISPOSITIVE POWER
10,668,712
- -------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
14,631,375
- -------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES |_|
- -------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
31.53%
- -------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
CO
- -------------------------------------------------------------------------------
SCHEDULE 13D
- -------------------------------------------------------------------------------
CUSIP No. 232808105
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Defiante Farmaceutica L.D.A.
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |X|
(b) |_|
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 SOURCE OF FUNDS
- -------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
- -------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Portugal
- -------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 0
SHARES ------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 14,631,375
EACH
REPORTING ------------------------------------------------------
PERSON WITH 9 SOLE DISPOSITIVE POWER
0
------------------------------------------------------
10 SHARED DISPOSITIVE POWER
2,025,315
- -------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
14,631,375
- -------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES |_|
- -------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
31.53%
- -------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
CO
- -------------------------------------------------------------------------------
SCHEDULE 13D
- -------------------------------------------------------------------------------
CUSIP No. 232808105
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Aptafin S.p.A.
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |X|
(b) |_|
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 SOURCE OF FUNDS
- -------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
- -------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Italy
- -------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 0
SHARES ------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 14,631,375
EACH ------------------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON WITH 0
------------------------------------------------------
10 SHARED DISPOSITIVE POWER
11,117,812
- -------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
14,631,375
- -------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES |_|
- -------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
31.53%
- -------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
CO
- -------------------------------------------------------------------------------
Amendment No. 6 and
Amendment No. 8 to
Statement on Schedule 13D
This Amendment No. 6 (the "Amendment No. 6") amends the Statement on
Schedule 13D filed with the Securities and Exchange Commission ("SEC") on
March 25, 2002 (the "Sigma/Defiante Schedule 13D"), as amended, relating to
shares of the common stock, no par value (the "Common Stock"), of Questcor
Pharmaceuticals Inc., a California corporation ("Questcor"). This Amendment
No. 8 (the "Amendment No. 8" and, together with the Amendment No. 6, this
"Statement") amends the Statement on Schedule 13D, filed with the SEC on
August 7, 2001 (the "Cavazza/Sigma Schedule 13D" and, together with the
Sigma/Defiante Schedule 13D, the "Schedule 13Ds"), as amended, relating to the
shares of Common Stock. Pursuant to Rule 13d-2 of Regulation 13D-G promulgated
under the Securities Exchange Act of 1934, as amended (the "Act"), this
Amendment No. 6 is being filed on behalf of Sigma-Tau Finanziaria SpA, an
Italian corporation ("Sigma Tau") and Defiante Farmaceutica L.D.A., a
Portuguese corporation ("Defiante") (formerly known as Defiante Farmaceutica
Unipessoal L.D.A.), and this Amendment No. 8 is being filed on behalf of
Sigma-Tau International S.A., a Luxembourg corporation ("Sigma Tau
International") (formerly known as Sigma-Tau Finance Holding S.A.), Aptafin
S.p.A., an Italian corporation ("Aptafin"), Mr. Claudio Cavazza ("Mr. C.
Cavazza") and Mr. Paolo Cavazza ("Mr. P. Cavazza" and, together with Mr. C.
Cavazza, Sigma Tau International, Aptafin, Defiante and Sigma Tau, the
"Reporting Persons").
Item 3. Source and Amount of Funds or Other Consideration.
-------------------------------------------------
Item 3 of the Schedule 13Ds are hereby amended to add the following,
which more specifically describes the transaction reported by the Reporting
Persons on January 13, 2004:
The 759,493 shares of Common Stock purchased by Defiante were
purchased from Questcor in a private placement on January 12, 2004. Questcor
sold the shares to Defiante in exchange for total consideration of
$489,113.51, consisting of $435,949.00 in cash and the surrender of 759,493
warrants held by Defiante (which were valued at $53,164.51 upon surrender).
Defiante used its working capital to provide the cash portion of the
consideration.
Item 4. Purpose of the Transaction.
--------------------------
Item 4 of the Schedule 13Ds are hereby amended to add the following:
The Reporting Persons originally acquired the shares reported herein
to gain an equity investment interest in Questcor. The Reporting Persons
acquired the shares described in Item 3 above upon their determination that
the purchase price for the shares provided for an attractive investment. The
Reporting Persons intend to evaluate on an ongoing basis Questcor's financial
condition, business operations and prospects. Based on such evaluations and
prevailing market conditions, the Reporting Persons will determine whether to
acquire or sell shares of Common Stock, subject to compliance with Section
16(b) of the Act and the rules promulgated thereunder.
None of the Reporting Parties has any present plans or proposals
which relate to or would result in any transaction, change or event specified
in clauses (a) through (j) of Item 4 of Schedule 13D.
Item 5. Interest in Securities of Questcor.
----------------------------------
Item 5(b) of the Schedule 13Ds are hereby amended as follows:
Aptafin
-------
The number of shares of Common Stock as to which Aptafin has the sole
power to vote or direct the vote is zero. The number of shares of Common Stock
as to which Aptafin shares the power to vote or direct the vote is 14,631,375.
The number of shares of Common Stock as to which Aptafin has the
sole power to dispose or direct the disposition is zero. The number of shares
of Common Stock as to which Aptafin shares the power to dispose or direct the
disposition is 11,117,812.
Item 7. Material to be Filed as Exhibits.
--------------------------------
EXHIBIT 1 - Joint Filing Agreement dated January 13, 2004 by and
between the Reporting Persons(1).
EXHIBIT 2 - Power of Attorney dated April 8, 2003 by and between the
Reporting Persons(2).
________________
(1) Incorporated by reference to Exhibit 1 of Amendment No. 5 and Amendment
No. 7 to the Statement on Schedule 13D, filed with the SEC on January 13,
2004, relating to the shares of Common Stock.
(2) Incorporated by reference to Exhibit 1 of Form 4, filed with the SEC on
May 9, 2003, relating to the shares of Common Stock.
Signatures
----------
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement with
respect to Claudio Cavazza is true, complete and correct.
Dated: January 15, 2004
CLAUDIO CAVAZZA
By: /s/ MAURIZIO TERENZI
------------------------------
Maurizio Terenzi, Attorney-in-
fact for Claudio Cavazza
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement with respect to
Paolo Cavazza is true, complete and correct.
Dated: January 15, 2004
PAOLO CAVAZZA
By: /s/ MAURIZIO TERENZI
------------------------------
Maurizio Terenzi, Attorney-in-
fact for Paolo Cavazza
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement with respect to
Sigma-Tau Finanziaria SpA is true, complete and correct.
Dated: January 15, 2004
SIGMA-TAU FINANZIARIA SPA
By: /s/ MAURIZIO TERENZI
------------------------------
Maurizio Terenzi, Attorney-in-
fact for Sigma-Tau Finanziari SpA
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement with respect to
Sigma-Tau International S.A. is true, complete and correct.
Dated: January 15, 2004
SIGMA-TAU INTERNATIONAL S.A.
By: /s/ MAURIZIO TERENZI
------------------------------
Maurizio Terenzi, Attorney-in-fact
for Sigma-Tau International S.A.
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement with respect to
Defiante Farmaceutica L.D.A. is true, complete and correct.
Dated: January 15, 2004
DEFIANTE FARMACEUTICA L.D.A.
By: /s/ MAURIZIO TERENZI
----------------------------------
Maurizio Terenzi, Attorney-in-fact
for Defiante Farmaceutica L.D.A.
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement with respect to
Aptafin S.p.A. is true, complete and correct.
Dated: January 15, 2004
APTAFIN S.P.A.
By: /s/ MAURIZIO TERENZI
----------------------------------
Maurizio Terenzi, Attorney-in-fact
for Aptafin S.p.A.
The original statement shall be signed by each person on whose behalf
the statement is filed or his authorized representative. If the statement is
signed on behalf of a person by his authorized representative (other than an
executive officer or general partner of the filing person), evidence of the
representative's authority to sign on behalf of such person shall be filed
with the statement: provided, however, that a power of attorney for this
purpose which is already on file with the Commission may be incorporated by
reference. The name and any title of each person who signs the statement shall
be typed or printed beneath his signature.
Attention: Intentional misstatements or omissions of fact constitute Federal
criminal violations (See 18 U.S.C. 1001)